Swiss Paediatric Airway Cohort

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age0-16
SponsorUniversity of Bern

About this trial

The Swiss Paediatric Airway Cohort (SPAC) is a national, prospective clinical cohort of children and adolescents who visit physicians in Switzerland for recurrent wheeze, cough, and exercise- or sleep-related respiratory problems. SPAC aims to answer important questions on clinical phenotypes, prognosis, diagnosis and treatment. SPAC is part of routine care, and only clinically indicated investigations are done. The comprehensive baseline assessment includes a detailed questionnaire to families, plus test results, diagnoses and treatments from hospital records. Follow-up is via monthly questionnaires the first 12 months and thereafter annual questionnaires to families, and data from follow-up visits.

Currently, 4344 patients from 10 clinics and hospitals in Switzerland (Aarau, Basel, Bern, Chur, Horgen, Lausanne, Luzern, St. Gallen, Worb, Zurich) have been enrolled.

SPAC provides real-life data on children visiting the Swiss health care system for common respiratory problems. It will provide a research platform for health services research, and for nested clinical and transitional studies.

Publications and plain language summaries are listed on the study website: https://www.spac-study.ch/publikationen/

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Children and adolescents aged 0-16 years

Resident in Switzerland

Seen in a paediatric pulmonary outpatient clinic due to respiratory problems

Parents and patients above age 14 must be able to sign an informed consent form

Disqualifiers

None

Trial population

Paediatric pulmonology outpatient clinics in Switzerland

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

6,000 Participants
are grouped into 1 trial group
Group A: Patient population

Trial outcomes

Primary outcomes

1

Wheeze

Number of patients with current wheeze as measured with questionnaire

Time frame
1 year from inclusion in SPAC study
2

Cough apart from colds

Number of patients with cough apart from colds as measured with questionnaires

Time frame
1 year from inclusion in SPAC study
3

Exercise-induced dyspnea

Number of patients with exercise-induced dyspnea as measured with questionnaires

Time frame
1 year from inclusion in SPAC study
4

Reduced lung function

Number of patients with reduced lung function measured through clinical tests in the paediatric pulmonary clinics (Spirometry, Fraction of Exhaled Nitric Oxide, Bronchial challenge test, Exercise challenge test). Information collected through hospital records.

Time frame
1 year from inclusion in SPAC study

Secondary outcomes

1

Wheeze

Number of patients with current wheeze as measured with questionnaire

Time frame
5 years from inclusion in SPAC study
2

Cough apart from colds

Number of patients with Cough apart from colds as measured with questionnaire

Time frame
5 years from inclusion in SPAC study
3

Exercise-induced dyspnea

Number of patients with Exercise-induced dyspnea as measured with questionnaire

Time frame
5 years from inclusion in SPAC study
4

Reduced lung function

Number of patients with reduced lung function measured through clinical tests in the paediatric pulmonary clinics (Spirometry, Fraction of Exhaled Nitric Oxide,

Time frame
5 years from inclusion in SPAC study

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.